This work is licensed under the Creative Commons Attribution 4.0 International License.
Jasani B, Weisz DE, McNamara PJ. Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants. Semin Perinatol 2018; 42(4):243–52.JasaniBWeiszDEMcNamaraPJ.Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants.2018;42(4):243–52.Search in Google Scholar
De Klerk JC, Engbers AG, Van Beek F, et al. Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review. Front Pediatr 2020; 8:541.De KlerkJCEngbersAGVan BeekF.Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review.2020;8:541.Search in Google Scholar
Fink D, Nitzan I, Bin-Nun A, et al. Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates. J Perinatol 2018; 38(11):1526–31.FinkDNitzanIBin-NunA.Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates.2018;38(11):1526–31.Search in Google Scholar
Hundscheid T, Onland W, Overmeire B Van, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr 2018; 18:262. doi: 10.1186/s12887-018-1215-7HundscheidTOnlandWOvermeireB Van.Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).2018;18:262. doi:10.1186/s12887-018-1215-7Open DOISearch in Google Scholar
Faim DRO, Tiago JAM, Castelo RJS, et al. Patent ductus arteriosus closure: Experience from a tertiary referral center. Rev Paul Pediatr 2020; 39:e2020013. doi: 10.1590/1984-0462/2021/39/2020013FaimDROTiagoJAMCasteloRJS.Patent ductus arteriosus closure: Experience from a tertiary referral center.2020;39:e2020013. doi:10.1590/1984-0462/2021/39/2020013Open DOISearch in Google Scholar
El-Mashad AE, El-Mahdy H, Amrousy D El, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 2017; 176:233–40. doi: 10.1007/s00431-016-2830-7El-MashadAEEl-MahdyHAmrousyD El.Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.2017;176:233–40. doi:10.1007/s00431-016-2830-7Open DOISearch in Google Scholar
Bardanzellu F, Neroni P, Dessì A, et al. Paracetamol in patent ductus arteriosus treatment: efficacious and safe? Biomed Res Int 2017; 2017:1438038. doi: 10.1155/2017/1438038.BardanzelluFNeroniPDessìA.Paracetamol in patent ductus arteriosus treatment: efficacious and safe?2017;2017:1438038. doi:10.1155/2017/1438038.Open DOISearch in Google Scholar
Al-lawama M, Alammori I, Abdelghani T, et al. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res 2018; 46:811–8. doi: 10.1177/0300060517722698Al-lawamaMAlammoriIAbdelghaniT.Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus.2018;46:811–8. doi:10.1177/0300060517722698Open DOISearch in Google Scholar
Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med 2016; 12:2531–6. doi: 10.3892/etm.2016.3676YangBGaoXRenY.Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial.2016;12:2531–6. doi:10.3892/etm.2016.3676Open DOISearch in Google Scholar
Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE 2013; 8:e77888. doi: 10.1371/journal.pone.0077888DangDWangDZhangC.Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial.2013;8:e77888. doi:10.1371/journal.pone.0077888Open DOISearch in Google Scholar
Karabulut B, Paytoncu S. Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants. Pediatr Drugs 2019; 21:113–21.KarabulutBPaytoncuS.Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants.2019;21:113–21.Search in Google Scholar
Nemerofsky SL, Parravicini E, Bateman D, et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol 2008; 25:661–6.NemerofskySLParraviciniEBatemanD.The ductus arteriosus rarely requires treatment in infants > 1000 grams.2008;25:661–6.Search in Google Scholar
Vaidya R, Knee A, Paris Y, et al. Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants. J Perinatol 2021; 41(5):998–1006.VaidyaRKneeAParisY.Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants.2021;41(5):998–1006.Search in Google Scholar
Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 2018; (4).OhlssonAShahPS.Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.2018; (4).Search in Google Scholar
Aikio O, Harkin P, Saarela T, et al. Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J Matern-Fetal Neonatal Med 2014; 27(12):1252–6.AikioOHarkinPSaarelaT.Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants.2014;27(12):1252–6.Search in Google Scholar
Terrin G, Conte F, Oncel MY, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: A systematic review and metaanalysis. Arch Dis Child: Fetal Neonatal Ed 2016; 101(2):F127–36.TerrinGConteFOncelMY.Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: A systematic review and metaanalysis.2016;101(2):F127–36.Search in Google Scholar
Höck M, Brunner B, Rier V, et al. Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants: Impact on outcome and pain perception. Pediatr Neonatol 2020; 61(1):84–91.HöckMBrunnerBRierV.Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants: Impact on outcome and pain perception.2020;61(1):84–91.Search in Google Scholar
Dash SK, Kabra NS, Avasthi BS, et al. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial. Indian Pediatr 2015; 52(7):573–8. doi: 10.1007/s13312-015-0677-zDashSKKabraNSAvasthiBS.Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial.2015;52(7):573–8. doi:10.1007/s13312-015-0677-zOpen DOISearch in Google Scholar
Härkin P, Härmä A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: A randomized trial. J Pediatr 2016; 177:72–7.HärkinPHärmäAAikioO.Paracetamol accelerates closure of the ductus arteriosus after premature birth: A randomized trial.2016;177:72–7.Search in Google Scholar
Bagheri MM, Bahman-Bijari B, Torabi-Nejad MH, et al. Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iran J Pediatr 2018; 28(4).BagheriMMBahman-BijariBTorabi-NejadMH.Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial.2018;28(4).Search in Google Scholar
Schindler T, Smyth J, Bolisetty S, et al. Early Paracetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatol 2021; 118:274–81. doi: 10.1159/000515415SchindlerTSmythJBolisettyS.Early Paracetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants.2021;118:274–81. doi:10.1159/000515415Open DOISearch in Google Scholar
Davidson JM, Ferguson J, Ivey E, et al. A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants [published online ahead of print, 2020]. J Perinatol. doi: 10.1038/s41372-020-0694-1DavidsonJMFergusonJIveyE.A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants [published online ahead of print, 2020].. doi:10.1038/s41372-020-0694-1Open DOISearch in Google Scholar
Asbagh PA, Zarkesh MR, Nili F, et al. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial. Tehran Univ Med J 2015; 73(2).AsbaghPAZarkeshMRNiliF.Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial.2015;73(2).Search in Google Scholar
Herrman K, Bose C, Lewis K, et al. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child: Fetal Neonatal Ed 2009; 94(1):F48–50.HerrmanKBoseCLewisK.Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit.2009;94(1):F48–50.Search in Google Scholar
Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30(4):241–52.BenitzWE.Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?2010;30(4):241–52.Search in Google Scholar
Semberova J, Sirc J, Miletin J, et al. Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g. Pediatr 2017; 140(2).SemberovaJSircJMiletinJ.Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g.2017;140(2).Search in Google Scholar
Goyal R, Goyal D, Longo LD, et al. Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition. Pediatr Res 2016; 80(4):610–8.GoyalRGoyalDLongoLD.Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition.2016;80(4):610–8.Search in Google Scholar
Hamrick SE, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant. Pediatr 2020; 146(5).HamrickSESallmonHRoseAT.Patent ductus arteriosus of the preterm infant.2020;146(5).Search in Google Scholar
Olsson KW, Jonzon A, Sindelar R. A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22–27 weeks gestational age. Crit Care Res Pract 2012; 2012:715265.OlssonKWJonzonASindelarR.A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22–27 weeks gestational age.2012;2012:715265.Search in Google Scholar
Kumar J, Dutta S, Sundaram V, et al. Platelet transfusion for PDA closure in preterm infants: A randomized controlled trial. Pediatr 2019; 143(5):e20182565.KumarJDuttaSSundaramV.Platelet transfusion for PDA closure in preterm infants: A randomized controlled trial.2019;143(5):e20182565.Search in Google Scholar
Kahvecioglu D, Erdeve O, Akduman H, et al. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in prematurity. Pediatr Neonatol 2018; 59(1):53–7.KahveciogluDErdeveOAkdumanH.Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in prematurity.2018;59(1):53–7.Search in Google Scholar